Cerebrotendinous xanthomatosis: case report with evidence of oxidative stress

REFERENCES

• Moghadasian MH. Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds. Clin Invest Med 2004; 27: 42–50.
   PubMed Web of Science ®Google Scholar
• Guyant-Marechal L, Verrips A, Girard C et al. Unusual cerebrotendinous xanthomatosis with fronto-temporal dementia phenotype. Am J Med Genet A 2005; 139: 114–117.
   Google Scholar
• Lorincz MT, Rainier S, Thomas D, Fink JK. Cerebrotendinous xanthomatosis: possible higher prevalence than previously recognized. Arch Neurol 2005; 62: 1459–1463.
   PubMed Web of Science ®Google Scholar
• Sugama S, Kimura A, Chen W et al. Frontal lobe dementia with abnormal cholesterol metabolism and heterozygous mutation in sterol 27-hydroxylase gene (CYP27). J Inherit Metab Disord 2001; 24: 379–392.
   PubMed Web of Science ®Google Scholar
• Dotti MT, Federico A, Garuti R, Calandra S. Cerebrotendinous xanthomatosis with predominant parkinsonian syndrome: further confirmation of the clinical heterogeneity. Mov Disord 2000; 15: 1017–1019.
   PubMed Web of Science ®Google Scholar
• Ohno T, Kobayashi S, Hayashi M, Sakurai M, Kanazawa I. Diphenylpyraline-responsive parkinsonism in cerebrotendinous xanthomatosis: long-term follow up of three patients. J Neurol Sci 2001; 182: 95–97.
   PubMed Web of Science ®Google Scholar
• Frih-Ayed M, Boughammoura-Bouatay A, Ben Hamda K, Chebel S, Ben Farhat M. [Hypertrophy of the atrial septum in the cerebrotendinous xanthomatosis]. Rev Med Intern 2005; 26: 992–993.
   PubMed Web of Science ®Google Scholar
• Isenhardt K, Schmitt R, Nagel A, Drach L, Schlote W. Inheritedcholesterol lipidosis: cerebrotendinous xanthomatosis (van Bogaert Scherer Epstein disease). A clinicopathological study. Clin Neuropathol 2005; 24: 276–283.
   PubMed Web of Science ®Google Scholar
• De Stefano N, Dotti MT, Mortilla M, Federico A. Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis. Brain 2001; 124: 121–131.
   PubMed Web of Science ®Google Scholar
• Barkhof F, Verrips A, Wesseling P et al. Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Radiology 2000; 217: 869–876.
   PubMed Web of Science ®Google Scholar
• Berginer VM, Salen G, Shefer S. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med 1984; 311: 1649–1652.
   PubMed Web of Science ®Google Scholar
• Mondelli M, Sicurelli F, Scarpini C, Dotti MT, Federico A. Cerebrotendinous xanthomatosis: 11-year treatment with chenodeoxycholic acid in five patients. An electrophysiological study. J Neurol Sci 2001; 190: 29–33.
   PubMed Web of Science ®Google Scholar
• Peynet J, Laurent A, De Liege P et al. Cerebrotendinous xantho-matosis: treatments with simvastatin, lovastatin, and chenodeoxy-cholic acid in 3 siblings. Neurology 1991; 41: 434–436.
   PubMed Web of Science ®Google Scholar
• Siman-Tov T, Meiner V, Gadoth N. Could steroids mask the diagnosis of cerebrotendinous xanthomatosis? J Neurol Sci 2006; 243: 83–86.
   PubMed Web of Science ®Google Scholar
• Seyama Y. Cholestanol metabolism, molecular pathology, and nutritional implications. J Med Food 2003; 6: 217–224.
   PubMedGoogle Scholar
• Dotti MT, Salen G, Federico A. Cerebrotendinous xanthomatosis as a multisystem disease mimicking premature ageing. Dev Neurosci 1991; 13: 371–376.
   PubMed Web of Science ®Google Scholar
• Nunomura A, Castellani RJ, Zhu X, Moreira PI, Perry G, Smith MA. Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol 2006; 65: 631–641.
   PubMed Web of Science ®Google Scholar
• Schleicher ED, Wagner E, Nerlich AG. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyplysine in human tissues in diabetes and aging. J Clin Invest 1997; 99: 457–468.
   PubMed Web of Science ®Google Scholar
• Sabadini L, Gonnelli L, Anichini C et al. [Cerebrotendinous xantho-matosis. A case report]. Recenti Prog Med 1996; 87: 110–113.
   PubMedGoogle Scholar
• Monnier VM, Nagaraj RH, Portero-Otin M et al. Structure of advanced Maillard reaction products and their pathological role. Nephrol Dial Transplant 1996; 11 (Suppl 5): 20–26.
   PubMedGoogle Scholar
• Castellani RJ, Harris PL, Sayre LM et al. Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine. Free Radic Biol Med 2001; 31: 175–180.
   PubMed Web of Science ®Google Scholar
• Castellani RI, Perry G, Harris PL, Monnier VM, Cohen ML, Smith MA. Advanced glycation modification of Rosenthal fibers in patients with Alexander disease. Neurosci Lett 1997; 231: 79–82.
   PubMed Web of Science ®Google Scholar
• Castellanl R, Smith MA, Richey PL, Perry G. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res 1996; 737: 195–200.
   PubMed Web of Science ®Google Scholar
• Broughton 2nd G. Chenodeoxycholate: the bile acid. The drug. a review. Am J Med Sci 1994; 307: 54–63.
   PubMed Web of Science ®Google Scholar
• Smith MA, Casadesus G, Joseph JA, Perry G. Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain. Free Radic Biol Med 2002; 33: 1194–1199.
   PubMed Web of Science ®Google Scholar
• Lee HG, Perry G, Moreira PI et al. Tau phosphorylation in Alzheimer's disease: pathogen or protector? Trends Mol Med 2005; 11: 164–169.
   PubMed Web of Science ®Google Scholar
• Castellani RI, Lee HG, Zhu X, Nunomura A, Perry G, Smith MA. Neuropathology of Alzheimer disease: pathognomonic but not pathogenic. Acta Neuropathol (Berl) 2006; 111: 503–509.
   PubMed Web of Science ®Google Scholar
• Moghadasian MH, Salen G, Frohlich JJ, Scudamore CH. Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations. Arch Neurol 2002; 59: 527–529.
   PubMedGoogle Scholar
• Castellani RI, Perry G, Smith M et al. Active glycation in neurofibrillary pathology of Alzheimer's disease: N-(carboxymethyl) lysine and hexitol-lysine. Free Radic Biol Med 2001; 31: 175–180.
   PubMed Web of Science ®Google Scholar
• Virmani R, Burke A, Farb A. Sudden cardiac death. Cardiovasc Pathol 2001; 10: 275–282.
   PubMed Web of Science ®Google Scholar
• Nashef L, Fish DR, Garner S, Sander JWAS, Shorvon SD. Sudden death in epilepsy: a study of incidence in a young cohort with epilepsy and learning difficulty. Epilepsia 1995; 36: 1187–1194.
   PubMed Web of Science ®Google Scholar
• Lip GYH, Brodie MJ. Sudden death in epilepsy: an avoidable outcome? J R Soc Med 1992; 85: 609–611.
   PubMed Web of Science ®Google Scholar